Centro Médico Fleischer

Buenos Aires C1414DRK

2 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, HER2-positive Breast Cancer

Studies at this site

• RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive — Recruiting now
• A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer — Recruiting now